22-42385181-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_145912.8(NFAM1):c.793C>T(p.Leu265=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000948 in 1,613,428 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0049 ( 10 hom., cov: 32)
Exomes 𝑓: 0.00054 ( 8 hom. )
Consequence
NFAM1
NM_145912.8 synonymous
NM_145912.8 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.140
Genes affected
NFAM1 (HGNC:29872): (NFAT activating protein with ITAM motif 1) The protein encoded by this gene is a type I membrane receptor that activates cytokine gene promoters such as the IL-13 and TNF-alpha promoters. The encoded protein contains an immunoreceptor tyrosine-based activation motif (ITAM) and is thought to regulate the signaling and development of B-cells. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 22-42385181-G-A is Benign according to our data. Variant chr22-42385181-G-A is described in ClinVar as [Benign]. Clinvar id is 787508.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.14 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0049 (747/152306) while in subpopulation AFR AF= 0.0174 (721/41546). AF 95% confidence interval is 0.0163. There are 10 homozygotes in gnomad4. There are 342 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 10 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NFAM1 | NM_145912.8 | c.793C>T | p.Leu265= | synonymous_variant | 6/6 | ENST00000329021.10 | NP_666017.1 | |
NFAM1 | NM_001371362.1 | c.637C>T | p.Leu213= | synonymous_variant | 8/8 | NP_001358291.1 | ||
NFAM1 | NM_001318323.3 | c.*83C>T | 3_prime_UTR_variant | 5/5 | NP_001305252.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NFAM1 | ENST00000329021.10 | c.793C>T | p.Leu265= | synonymous_variant | 6/6 | 1 | NM_145912.8 | ENSP00000333680 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00488 AC: 743AN: 152188Hom.: 10 Cov.: 32
GnomAD3 genomes
AF:
AC:
743
AN:
152188
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00138 AC: 345AN: 250428Hom.: 5 AF XY: 0.00104 AC XY: 141AN XY: 135466
GnomAD3 exomes
AF:
AC:
345
AN:
250428
Hom.:
AF XY:
AC XY:
141
AN XY:
135466
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000535 AC: 782AN: 1461122Hom.: 8 Cov.: 29 AF XY: 0.000484 AC XY: 352AN XY: 726986
GnomAD4 exome
AF:
AC:
782
AN:
1461122
Hom.:
Cov.:
29
AF XY:
AC XY:
352
AN XY:
726986
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00490 AC: 747AN: 152306Hom.: 10 Cov.: 32 AF XY: 0.00459 AC XY: 342AN XY: 74478
GnomAD4 genome
AF:
AC:
747
AN:
152306
Hom.:
Cov.:
32
AF XY:
AC XY:
342
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 19, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at